Monoclonal antibody therapy involving four quick injections works “essentially” as well in helping patients recover from COVID-19 as the more cumbersome intravenous infusions, according to a recent ...
The first immune checkpoint inhibitor that can be administered via subcutaneous injection in just 1 to 2 minutes has emerged.